LZLoukia Zerva

Loukia Zerva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Loukia Zerva has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Nikolaos Siafakas

    Laboratory of Clinical Microbiology, ATTIKON University Hospital, Athens, Greece

    2 shared publications
  • Anastasia Antoniadou

    1 shared publication
  • Christos Iatrou

    G. Papadakis' Center for Nephrology General Hospital of Nikaia Pireus

    1 shared publication
  • Efthymia Petinaki

    Department of Microbiology, Medical School, University of Thessaly, Larissa, Greece

    1 shared publication
  • Eleftheria Baimakou

    Laboratory of Microbiology and Biochemistry Areteion Hospital University of Athens Athens

    1 shared publication
  • Evangelia Kouskouni

    Laboratory of Microbiology and Biochemistry Areteion Hospital University of Athens Athens

    1 shared publication

Latest Publications

  • fblgene as a species-specific target forStaphylococcus lugdunensisidentification

    by Kalliopi-Stavroula Chatzigeorgiou, Nikolaos Siafakas, Efthymia Petinaki, Loukia Zerva

    Staphylococcus lugdunensis is an unusually virulent coagulase‐negative species, associated with severe infections. The present report describes the development of a single‐step, species‐specific PCR protocol for S. lugdunensis identification. fbl gene, encoding a fibrinogen‐binding adhesin, was exploited and assessed as a suitable nucleic acid target. The gene was detected in all 17 S. lugdunensis isolates examined, while no amplification product was obtained from 98 isolates representing 11 staphylococcal and 17 nonstaphylococcal species. Forty‐seven percent of the S. lugdunensis strains produced a positive slide coagulase reaction, which is consistent with varying levels of Fbl protein expression within the species. J. Clin. Lab. Anal. 24:119–122, 2010.


  • Colonisation with vancomycin- and linezolid-resistant Enterococcus faecium in a university hospital: molecular epidemiology and risk factor analysis

    by Maria Souli, Vissaria Sakka, Irene Galani, Anastasia Antoniadou, Lambrini Galani, Nikolaos Siafakas, Loukia Zerva, Helen Fytrou, Sotirios Tsiodras, Helen Giamarellou


  • Open Access

    Dissemination of vancomycin-resistant enterococci among haemodialysis patients in Athens, Greece

    by Petros Kalocheretis, Eleftheria Baimakou, Sinodi Zerbala, Joseph Papaparaskevas, Ioanna Makriniotou, Panayotis T. Tassios, Christos Iatrou, Evangelia Kouskouni, Loukia Zerva

    Objectives: Vancomycin-resistant enterococci (VRE) may colonize haemodialysis patients, but their epidemiology in this population is not well defined. Within the few last years, VRE strains have emerged and are increasingly isolated in the nosocomial environment in Greece, but colonization of dialysis patients has never been evaluated before. This study sought to determine the epidemiology of VRE colonization within this high-risk population and define the risk factors. Materials and methods: During a 4 month period, rectal swabs or faecal specimens were collected from 334 consecutive outpatients, who were treated at four independent dialysis units located in the same area of Athens and referring patients to the same local hospital. The relatedness of isolates was defined by molecular typing, and demographic and clinical patient data were recorded. Results: Thirteen multiresistant Enterococcus faeciumvanA strains were isolated corresponding to a colonization frequency of 3.9%. They were separated into seven clusters: type A (two strains), type B (six strains) and types C to G (one strain each). Type B strains originated from three units, while a single unit demonstrated four type B and two type A strains. Univariate statistical analysis revealed that prior hospitalization (P=0.001), prior administration of antimicrobials (P=0.026) and male gender (P=0.019) were associated with VRE colonization. Conclusions: In Greece, haemodialysis patients are colonized with VRE at a low frequency. The predominance of one clone and its isolation from several units strongly indicate interfacility transmission of strains, most probably within a health care environment shared by all patients.